Accel Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Accel Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-61	Closed	-$35.2K	–	796
2023 Q1	$35.2K	Hold	61	–	–	0.01%	565
2022 Q4	$33.6K	Hold	61	–	–	0.02%	433
2022 Q3	$33K	Sell	61 -8	-12%	-$4.48K	0.02%	449
2022 Q2	$37K	Buy	69 +11	+19%	+$6.05K	0.02%	409
2022 Q1	$34K	Hold	58	–	–	0.02%	446
2021 Q4	$39K	Buy	58 +8	+16%	+$5K	0.02%	428
2021 Q3	$29K	Hold	50	–	–	0.02%	431
2021 Q2	$25K	Hold	50	–	–	0.02%	480
2021 Q1	$23K	Buy	+50	New	+$23.9K	0.02%	472

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Accel Wealth Management's TMO Position: Q2 2023 in Review

Accel Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 61 shares — an estimated $35.2K sold.

Accel Wealth Management first reported a position in TMO in Q1 2021 and held it in 9 quarters. The position peaked at $39K in Q4 2021. 2,389 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

Accel Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
Accel Wealth Management sold 61 Thermo Fisher Scientific shares in Q2 2023, an estimated $35.2K.
Accel Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 9 quarters.
Accel Wealth Management's Thermo Fisher Scientific position peaked at $39K in Q4 2021.
2,389 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.